<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://finance.naver.com/news/news_list.naver?mode=LSS3D&amp;section_id=101&amp;section_id2=258&amp;section_id3=402</id>
    <title>네이버 금융 ─ 뉴스 ─ 기업 종목분석</title>
    <updated>2021-11-12T00:21:19.958Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://finance.naver.com/news/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[[fn종목 돋보기] 캐리소프트, 해외에서 더 인기...'한국판 로블록스' 주목]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004738571&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004738571&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.829Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004738571&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="[fn종목 돋보기] 캐리소프트, 해외에서 더 인기...'한국판 로블록스' 주목">[fn종목 돋보기] 캐리소프트, 해외에서 더 인기...'한국판 로블록스' 주목</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[단독] '대세' 박민지 소속사 YG스포츠, 신생 PEF에 팔린다]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004878048&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004878048&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.830Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004878048&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="[단독] '대세' 박민지 소속사 YG스포츠, 신생 PEF에 팔린다">[단독] '대세' 박민지 소속사 YG스포츠, 신생 PEF에 팔린다</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주] 렉키로나 유럽 '승인 권고' 획득...셀트리온3사 주가 '들썩']]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0003984474&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0003984474&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.835Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0003984474&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="[특징주] 렉키로나 유럽 '승인 권고' 획득...셀트리온3사 주가 '들썩'">[특징주] 렉키로나 유럽 '승인 권고' 획득...셀트리온3사 주가 '들썩'</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[툴젠, SML제니트리와 차세대 암 진단키트 개발 협약]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004627603&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004627603&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.835Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004627603&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="툴젠, SML제니트리와 차세대 암 진단키트 개발 협약">툴젠, SML제니트리와 차세대 암 진단키트 개발 협약</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[셀트리온 3형제, 렉키로나 유럽 승인권고 소식에 급등]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004669570&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004669570&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.835Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004669570&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="셀트리온 3형제, 렉키로나 유럽 승인권고 소식에 급등">셀트리온 3형제, 렉키로나 유럽 승인권고 소식에 급등</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[크래프톤, 3분기 호실적에 신작 기대감...목표가 11% ↑-신한금융투자]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004738566&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004738566&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.835Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004738566&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="크래프톤, 3분기 호실적에 신작 기대감...목표가 11% ↑-신한금융투자">크래프톤, 3분기 호실적에 신작 기대감...목표가 11% ↑-신한금융투자</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주] 리비안, 상장 '흥행몰이'에 관련주 '강세']]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0000996429&amp;office_id=215&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0000996429&amp;office_id=215&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.837Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0000996429&amp;office_id=215&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="[특징주] 리비안, 상장 '흥행몰이'에 관련주 '강세'">[특징주] 리비안, 상장 '흥행몰이'에 관련주 '강세'</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[“SK바이오팜, 中 법인 설립이 회사 가치 끌어올릴 것”]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004627585&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004627585&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1"/>
        <updated>2021-11-12T00:19:40.838Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004627585&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211112&amp;page=1" title="“SK바이오팜, 中 법인 설립이 회사 가치 끌어올릴 것”">“SK바이오팜, 中 법인 설립이 회사 가치 끌어올릴 것”</a>]]></content>
    </entry>
</feed>